To Explore Whether the Application of Intelligent Hypertension Management System Can Effectively Reduce Blood Pressure in Hypertensive Patients
Conditions
Brief summary
To explore whether the application of intelligent hypertension management system can effectively reduce blood pressure in hypertensive patients. A total of 320 eligible subjects will be recruited and randomization to two groups. The standard care group (n=160) will receive conventional hypertension treatment with baseline data collected.Wearable blood pressure monitoring device management group (intervention group, n=160) will receive blood pressure monitoring remotely everyday and antihypertension medication treatment. Primary outcome is Net change in systolic blood pressure from baseline to 3 months follow-up. Secondary outcomes include Net change in diastolic blood pressure hypertension control ratio (BP \< 140/90 mmHg)
Interventions
DEVICEIntelligent Hypertension Management System
The intelligent hypertension management system is used to remotely detect the blood pressure of hypertensive patients
OTHERThe standard care
The standard care
Sponsors
Shanghai Tong Ren Hospital
Study design
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
1. Aged more than 18 years old, less than or equal to 75 years old. 2. Hypertensive patients (systolic/diastolic blood pressure ≥140/90 mmHg at two separate screening/baseline visits) 3. Patients or guardians can skillfully use devices such as smartphones and electronic sphygmomanometers 4. Voluntarily joined and signed the informed consent
Exclusion criteria
1. Pregnant women or women planning to become pregnant within the next year; 2. Patients with secondary hypertension 3. Patients with life expectancy less than 1 year 4. Severe hepatic and renal insufficiency (ALT \> 5 times ULA, eGFR \< 15ml/min/1.73mm2) 5. Known active malignancy disease 6. The researcher believes that patients who are not suitable to participate in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Net change in systolic blood pressure from baseline to 3 months follow-up | one and three months after study |
Secondary
| Measure | Time frame |
|---|---|
| Net change in diastolic blood pressure | one and three months after study |
| Hypertension control ratio (BP < 140/90 mmHg) | one and three months after study |
Countries
China
Outcome results
None listed